Virus-resistant mosquitoes to be unleashed in Colombia, Brazil

October 26, 2016

Governments and philanthropists on Wednesday announced an $18 million plan to release mosquitoes resistant to Zika, dengue and other viruses in urban areas of Colombia and Brazil.

The program aims to boost mosquito-control efforts by using Wolbachia bacteria beginning next year, following the alarming spread of the mosquito-borne Zika virus, which can cause devastating birth defects.

Wolbachia occurs naturally in 60 percent of insects, but not mosquitoes.

Research and field trials over the past several years in countries such as Australia, Indonesia and Vietnam have shown that injecting mosquitoes with the bacteria significantly reduces their ability to spread viruses to people.

Funders of the effort include USAID, the British government, the global charity Wellcome and the Bill and Melinda Gates Foundation.

"Using Wolbachia to reduce the transmission of mosquito-borne diseases has the potential to greatly reduce the global health burden and socio-economic cost of Zika and other related infections like dengue and yellow fever," said Wellcome's Mike Turner, acting director of science and head of infection and immunobiology.

"This research is essential as it will help measure the health impact of the Wolbachia method in large , where these kinds of outbreaks can have such a devastating impact."

The process of inoculating Aedes aegypti mosquitoes—which carry the viruses—with Wolbachia was developed by the Eliminate Dengue Program, a non-profit international research collaboration led by Australia's Monash University.

Small-scale field trials began in Rio de Janeiro in 2014 and Bello, Colombia—a suburb of northwestern Medellin—in 2015.

The new cash injection will "finance the rapid scale up of Wolbachia deployments in Latin America, commencing in early 2017," a statement from the funders said.

"Wolbachia coverage will be extended across Bello and other parts of Antioquia and now across parts of the greater Rio de Janeiro area."

Scientists say they will study the areas over the next two to three years to determine the impact on human health, in the hope the releases will significantly reduce new cases of Zika, dengue and chikungunya.

Explore further: Bill Gates urges UK to invest in science as Brexit looms

Related Stories

Bill Gates urges UK to invest in science as Brexit looms

October 26, 2016
US billionaire philanthropist Bill Gates urged Britain on Wednesday to step up investment in science and research as it prepares to leave the EU.

Inheritable bacterium controls Aedes mosquitoes' ability to transmit Zika

May 4, 2016
Aedes mosquitoes carrying the bacterium Wolbachia—found inside the cells of 60 percent of all insect species—are drastically less able to transmit Zika virus, say researchers at Brazil's Oswaldo Cruz Foundation (FIOCRUZ) ...

Benign bacteria block mosquitoes from transmitting Zika, chikungunya viruses

July 1, 2016
Researchers at the University of Wisconsin-Madison have confirmed that a benign bacterium called Wolbachia pipientis can completely block transmission of Zika virus in Aedes aegypti, the mosquito species responsible for passing ...

Dengue program expands outlook

December 30, 2014
Scaling up to take on large urban areas is the latest challenge for the Eliminate Dengue program, which tackles the disease by seeding infected areas with mosquitoes infected by a particular bacterium. 

A quick and easy new method to detect Wolbachia bacteria in intact Aedes mosquitoes

June 30, 2016
Aedes aegypti mosquitoes transmit dengue, chikungunya, and zika viruses. A study published in PLOS Neglected Tropical Diseases reports a new technique that could make one approach to mosquito control—using Wolbachia bacteria ...

Wolbachia parasite superinfection: A new tool to fight mosquito arbovirus transmission

February 18, 2016
Aedes aegypti mosquitoes transmit a number of pathogens, including the Dengue, Chikungunya, and Zika viruses. Wolbachia, a bacterium that naturally infects many insect species but not Aedes aegypti, can nonetheless be introduced ...

Recommended for you

Infants born to obese mothers risk developing liver disease, obesity

November 16, 2018
Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers ...

New study shows NKT cell subsets play a large role in the advancement of NAFLD

November 16, 2018
Since 2015 it has been known that the gut microbiota could have a direct impact on nonalcoholic fatty liver disease (NAFLD), which affects up to 12% of adults and is a leading cause of chronic liver disease. In the November ...

Antibiotic prescribing influenced by team dynamics within hospitals

November 15, 2018
Antibiotic prescribing by doctors is influenced by team dynamics and cultures within hospitals.

Discovery suggests new route to fight infection, disease

November 14, 2018
New research reveals how a single protein interferes with the immune system when exposed to the bacterium that causes Legionnaires' disease, findings that could have broad implications for development of medicines to fight ...

Zika may hijack mother-fetus immunity route

November 14, 2018
To cross the placenta, Zika virus may hijack the route by which acquired immunity is transferred from mother to fetus, new research suggests.

New research aims to help improve uptake of hepatitis C testing

November 14, 2018
New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the hepatitis C Virus (HCV).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.